Sanofi settles dispute with Genzyme investors over MS drugSanofi has settled a long-running dispute with shareholders in the biotech Genzyme, who claimed the big pharma deliberately Share XSanofi settles dispute with Genzyme investors over MS drughttps://pharmaphorum.com/news/sanofi-settles-dispute-with-genzyme-investors-over-ms-drug/
J&J refutes FDA findings on asbestos in talcJohnson & Johnson has rejected an assertion by the FDA that asbestos had been found in one of Share XJ&J refutes FDA findings on asbestos in talchttps://pharmaphorum.com/news/jj-refutes-fda-findings-on-asbestos-in-talc/
Allergan pays $750m to avoid Alzheimer’s drug lawsuitAllergan has agreed to pay $750 million to settle lawsuits in the US brought by direct purchasers of Share XAllergan pays $750m to avoid Alzheimer’s drug lawsuithttps://pharmaphorum.com/news/allergan-pays-750m-to-avoid-alzheimers-drug-lawsuit/
Major US retailers pull J&J’s talc from shelves over asbestos fearsA trio of major US retailers including Walmart are removing all 22-ounce bottles of Johnson & Johnson’s baby Share XMajor US retailers pull J&J’s talc from shelves over asbestos fearshttps://pharmaphorum.com/news/major-us-retailers-pull-jjs-talc-from-shelves-over-asbestos-fears/
Lawsuit-laden J&J recalls baby powder after asbestos alertJohnson & Johnson has said it is recalling around 33,000 bottles of baby powder in the US, after Share XLawsuit-laden J&J recalls baby powder after asbestos alerthttps://pharmaphorum.com/news/lawsuit-laden-jj-recalls-baby-powder-after-asbestos-alert/
J&J brushes off concerns over talc, opioid and Risperdal litigationJohnson & Johnson has brushed off investors’ concerns over the many lawsuits it is facing, saying its legal Share XJ&J brushes off concerns over talc, opioid and Risperdal litigationhttps://pharmaphorum.com/news/jj-brushes-off-concerns-over-litigation/
US court tells J&J to pay $8bn damages to man over breast growthA court has told Johnson & Johnson to pay $8 billion in punitive damages to a man who Share XUS court tells J&J to pay $8bn damages to man over breast growthhttps://pharmaphorum.com/news/us-court-tells-jj-to-pay-8bn-damages-to-man-over-breast-growth/
Drug firms colluded to hike essential medicine price by 1,800%, says UK watchdogThe UK’s competition watchdog has provisionally found three drug firms signed an illegal agreement, resulting in huge price Share XDrug firms colluded to hike essential medicine price by 1,800%, says UK watchdoghttps://pharmaphorum.com/news/drug-firms-colluded-to-hike-essential-medicine-price-by-1800-says-uk-watchdog/
France’s Servier finally goes on trial over Mediator safety scandalMore than a decade after a scandal over drug safety in France first broke, the pharma company Servier Share XFrance’s Servier finally goes on trial over Mediator safety scandalhttps://pharmaphorum.com/news/frances-servier-finally-goes-on-trial-over-mediator-safety-scandal/
